Open Your FREE Demat Account Now!

Hester Biosciences Ltd. Share Price

NSE
BSE

NSE : HESTERBIO

BSE : 524669

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹2,140.10

High

₹2,260.00

Price Summary

Previous Close ₹2,243.70
Day's Range ₹2,140.10 - ₹2,260.00
Open ₹2,163.80
52 Week Range ₹1,239.30 - ₹2,683.60
Volume 3,010
Market Cap ₹0.00
Previous Close ₹2,223.80
Day's Range ₹2,135.30 - ₹2,258.30
Open ₹2,175.00
52 Week Range ₹1,250.95 - ₹2,669.00
Volume 296
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 67.54
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.51
Price/Earning (TTM) 13.39
TTM EPS (₹) 160.08
P/E Ratio 19.31
Book Value(₹) 4.01
PAT Margin (%) 17.27
Face Value (₹) 10.00
ROCE(%) 16.21
Trade Value ( ₹ in Lacs) 6.58
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.51
Price/Earning (TTM) 13.39
TTM EPS (₹) 160.08
P/E Ratio 19.31
Book Value(₹) 4.01
PAT Margin (%) 17.27
Face Value (₹) 10.00
ROCE(%) 16.21

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 841.05 3111.02
Expenses N/A N/A
PBT 201.87 395.71
Operating profit 0.0 0.0
Net profit 172.96 288.26

Shareholding Pattern

Promoters (% Holding)

44.28%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

55.33%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.30%

About Hester Biosciences Ltd.

Founded 1987
Managing Director Rajiv Gandhi
NSE Symbol HESTERBIO

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,22,282.95 1,758.00 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,51,611.12 9,561.70 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,75,182.22 4,560.35 3,532.60 - 3,532.60
Lenskart Solutions Ltd. 1,16,411.76 689.70 0.00 - 0.00
Zydus Lifesciences Ltd. 1,16,408.70 1,172.00 835.50 - 835.50
Laurus Labs Ltd. 1,15,616.01 2,184.95 917.95 - 917.95
Apollo Hospitals Enterprise Ltd. 1,12,152.03 8,140.00 6,696.50 - 6,696.50
Cipla Ltd. 1,09,062.53 1,360.00 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,08,925.78 1,335.40 1,101.00 - 1,101.00
Mankind Pharma Ltd. 1,03,286.06 2,483.60 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Oct
28
2026
EQUITY Posted on Oct 28th 2026

Hester Biosciences submits analyst meet intimation

Hester Biosciences has informed that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has scheduled investor interaction through a teleconference call on Thursday, 5th November 2026 at 2:00 pm (IST), post the announcement of financial results for the quarter and six months period ended 30 September 2026. Details for joining the call are attached.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
27
2026
EQUITY Posted on Oct 27th 2026

Hester Biosciences informs about completion of tenure of independent director

Pursuant to provisions of Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Hester Biosciences has informed that, Ameetkumar Desai (DIN: 00007116) has informed the Company of his decision not to seek re-appointment for a second consecutive term as an Independent Director upon completion of his current first tenure on 27 October 2026. Consequently, effective closure of business hours on 27 October 2026, Ameetkumar Desai ceases to be an Independent Director of the Company. The Company placed on record its appreciation for the valuable contribution and support provided him during his association with the Company. The details as required under SEBI Listing Regulation read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026, are enclosed. 

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
14
2026
EQUITY Posted on Oct 14th 2026

Hester Biosciences informs about confirmation certificate

Hester Biosciences has informed that the details of securities dematerialised / rematerialised during the quarter ended 30 September 2026, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, has received from its Registrar and Share Transfer Agent - MUFG Intime India. A copy of confirmation certificate enclosed.
The above information is a part of company’s filings submitted to BSE. 
Read More
Sep
25
2026
EQUITY Posted on Sep 25th 2026

Hester Biosciences informs about closure of trading window

Hester Biosciences has informed that pursuant SEBI (Prohibition of Insider Trading) Regulations and the code of conduct of the Company to Regulate, Monitor and Report Trading by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and material subsidiaries of the Company, including the immediate relatives, the ‘Trading Window’ for dealing in equity shares of the Company shall remain closed from 1 October 2026 and will end 48 hours after the financial results of the Company for the quarter and six months period ended 30 September 2026 become generally available as public information.
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
28
2026
EQUITY Posted on Oct 28th 2026

Alembic Pharmaceuticals informs about press release

Alembic Pharmaceuticals has informed that it enclosed a e-copy of newspaper, containing the notice of loss of equity share certificate, published by the Company on behalf of the registered shareholder in English language newspaper - Business Standard on 28th October, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Hester Biosciences Ltd. ?

The current share price of Hester Biosciences Ltd. is ₹2,243.70 as of 2026-10-28.

The market capitalisation of Hester Biosciences Ltd. is ₹1,823.15 as of 2026-10-27.

The 1-year return of Hester Biosciences Ltd. is 597.00% as of 2026-10-28.

The P/E ratio of Hester Biosciences Ltd. is 19.31 as of 2026-10-28.

The 52-week high and low of Hester Biosciences Ltd. are ₹2,683.60 and ₹1,239.30, respectively, as of 2026-10-28.

The dividend yield of Hester Biosciences Ltd. is 0.5133% as of2026-10-27.

You can buy Hester Biosciences Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Hester Biosciences Ltd. is Rajiv Gandhi.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore